| abstract |
Sustained release formulation of a peptide, preferably a somatostatin such as octreotide, for example pamoate. The active ingredient is present in a polymer vehicle, preferably poly (lactic-co-glycolic acid). The formulation is preferably a depot formulation in the form of microparticles. The invention also includes an improved process for preparing microparticles of active principle in a biodegradable and biocompatible vehicle. |